Medical Education Division
Our Products
On-Line Store

Google
 
Web www.brooksidepress.org

Operational Medicine 2001
Emergency War Surgery
Second United States Revision of The Emergency War Surgery NATO Handbook
United States Department of Defense

Home  ·  Military Medicine  ·  Sick Call  ·  Basic Exams  ·  Medical Procedures  ·  Lab and X-ray  ·  The Pharmacy  ·  The Library  ·  Equipment  ·  Patient Transport  ·  Medical Force Protection  ·  Operational Safety  ·  Operational Settings  ·  Special Operations  ·  Humanitarian Missions  ·  Instructions/Orders  ·  Other Agencies  ·  Video Gallery  ·  Phone Consultation  ·  Forms  ·  Web Links  ·  Acknowledgements  ·  Help  ·  Feedback

 
 

Emergency War Surgery NATO Handbook: Part III: General Considerations of Wound Management: Chapter XV: Anesthesia and Analgesia

Induction of Anesthesia

United States Department of Defense


Time constraints and the risk of aspiration usually dictate that induction be rapid and controlled. Several intravenous agents are available which are in common use in the trauma setting. These include the rapidly acting barbiturates (such as thiopental), the benzodiazepines, rapidly acting narcotics, etomidate, and ketamine The overriding factors in the decision as to which drug is best relate to the adequacy of blood volume, history of allergic reaction, or recent food intake If the patient is markedly hypovolemic and there is insufficient time for fluid resuscitation, it is best to modify dosages of induction agents or use less cardiovascular depressant drugs, such as narcotics, etomidate, or ketamine. "Normal" dosages become lethal doses in the hypovolemic patient.

Some of the more important induction agents are:

Thiopental. This rapidly-acting barbiturate is quite familiar to most present day anesthetists. It has the advantages of fast onset, short duration, and good patient acceptance However, normal induction dosages may cause disastrous hypotension in the hypovolemic patient. An induction dose is 3-4 mg/kg intravenously, given over one minute in a solution of 2.5% or less in normal saline. This drug can be a potent cardiac depressant and can produce hypotension. It can cause laryngospasm immediately after or during induction, is a poor analgesic, and produces poor muscle relaxation. This drug is best used in combination with a muscle relaxant paralytic drug.

Etomidate. This drug usually preserves cardiovascular stability in the intact elective surgical patient but probably has no advantage over thiopental. in the case of hypovolemia. It also produces localized pain and myoclonic movements on rapid injection.

Ketamine. This agent is also fast acting, has analgesic properties, and supports the blood pressure by sympathetic stimulation. However, one must still be wary in the severely hypovolemic patient in whom sympathetic outflow may already be near maximal intensity. In these cases, the direct depressant effect on the myocardium may produce decreased cardiac output. Postoperative excitement and dysphoria, which is produced at times by this drug, may be minimized by using lower dosages or giving small amounts of benzodiazepines in combination with ketamine

Narcotics. Rapidly acting narcotics, such as sufentanil, in conjunction with benzodiazepines are an alternative induction technique. If newer agents, such as the narcotic alfentanil, and the benzodiazepine midazolam. prove safe in trauma cases, they should be considered also.

Regardless of the induction agent chosen, the risk of aspiration during induction (and emergence) remains a critical consideration. Drugs such as histamine receptor blockers, metaclopramide, and nonparticulate antacids offer promise as prophylactic measures; however, these agents will not be available on the battlefield, and the rapid and secure control of the airway remains the primary means of preventing this grave complication.

The anesthetist must ensure that an adequately functioning suction apparatus is close at hand and operational prior to induction or emergence.

 

 

 


Approved for public release; Distribution is unlimited.

The listing of any non-Federal product in this CD is not an endorsement of the product itself, but simply an acknowledgement of the source. 

Operational Medicine 2001

Health Care in Military Settings

Bureau of Medicine and Surgery
Department of the Navy
2300 E Street NW
Washington, D.C
20372-5300

Operational Medicine
 Health Care in Military Settings
CAPT Michael John Hughey, MC, USNR
NAVMED P-5139
  January 1, 2001

United States Special Operations Command
7701 Tampa Point Blvd.
MacDill AFB, Florida
33621-5323

This web version is provided by The Brookside Associates Medical Education Division.  It contains original contents from the official US Navy NAVMED P-5139, but has been reformatted for web access and includes advertising and links that were not present in the original version. This web version has not been approved by the Department of the Navy or the Department of Defense. The presence of any advertising on these pages does not constitute an endorsement of that product or service by either the US Department of Defense or the Brookside Associates. The Brookside Associates is a private organization, not affiliated with the United States Department of Defense.

Contact Us  ·  ·  Other Brookside Products

 

Advertise on this site